View ValuationBespoke Extracts 将来の成長Future 基準チェック /06現在、 Bespoke Extractsの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Pharmaceuticals 収益成長14.4%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報お知らせ • Nov 13Bespoke Extracts, Inc. Provides Earnings Guidance for the Fourth Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the fourth quarter of 2025. For the period, the company expects Revenue: Projected between $425,000 and $500,000, up 41%–66% year-over-year, driven by continued demand for Fresh Joints and expansion of Doobskis and Dutch Blunts.お知らせ • Aug 28Bespoke Extracts, Inc. Provides Earnings Guidance for the Third Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the third quarter of 2025. For the quarter, the company continue to experience sales growth in the new product lines compared the quarter ended September 30, 2024. The Company projects revenue between $425,000 and $450,000 for the quarter ending September 30, 2025, a 53% to 62% increase over $277,471 in the quarter ended September 30, 2024, driven by continued growth of FreshJoints, strong demand for Doobskis and Dutch Blunts, and expanded third-party processing services.すべての更新を表示Recent updatesお知らせ • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2026, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Nov 13Bespoke Extracts, Inc. Provides Earnings Guidance for the Fourth Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the fourth quarter of 2025. For the period, the company expects Revenue: Projected between $425,000 and $500,000, up 41%–66% year-over-year, driven by continued demand for Fresh Joints and expansion of Doobskis and Dutch Blunts.お知らせ • Aug 28Bespoke Extracts, Inc. Provides Earnings Guidance for the Third Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the third quarter of 2025. For the quarter, the company continue to experience sales growth in the new product lines compared the quarter ended September 30, 2024. The Company projects revenue between $425,000 and $450,000 for the quarter ending September 30, 2025, a 53% to 62% increase over $277,471 in the quarter ended September 30, 2024, driven by continued growth of FreshJoints, strong demand for Doobskis and Dutch Blunts, and expanded third-party processing services.お知らせ • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/14/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 02Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 04/01/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Nov 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 11/14/2023, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2023, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Nov 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 11/14/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/15/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 13Bespoke Extracts, Inc. (OTCPK:BSPK) entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million.Bespoke Extracts, Inc. (OTCPK:BSPK) entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million on August 12, 2022. Upon closing, Bespoke will issue 125,000,000 shares of common stock in exchange for the assets of Osiris. 50 percent of these shares will be subject to a six-month lockup period and 50 percent will be subject to a twelve-month lockup period. Bespoke has also agreed to assume up to $125,000 of equipment-based financing following the transaction. Bespoke will also be entering into leases for the Aspen Dispensary, the Glenwood Cultivation Facility and the Glenwood Dispensary. The transaction has been approved by the boards of directors of Bespoke and the members of Osiris and is subject to customary closing conditions, including approvals from Colorado regulatory authorities. The transaction is expected to close in the fourth calendar quarter of 2022.お知らせ • Jan 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 01/14/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Dec 03Bespoke Extracts, Inc. (OTCPK:BSPK) agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million.Bespoke Extracts, Inc. (OTCPK:BSPK) agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million on December 2, 2021. Total consideration is to be paid 100% in Bespoke common shares. Bespoke will issue 2.5 million shares as a deposit, and an additional $0.15 of shares at closing according to the daily volume weighted average price of Bespoke common stock for the 30 consecutive trading days prior to closing. The proposed transaction has been unanimously approved by the Bespoke board of directors and is expected to close upon receipt of state and local regulatory approvals and satisfaction of other customary closing conditions.お知らせ • Nov 30Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 11/29/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Apr 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 04/14/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Feb 26Bespoke Extracts, Inc. announced that it has received $0.5 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced a securities purchase agreement for a private placement of 10,000,000 shares at an issue price of $0.05 per share for gross proceeds $500,000 on February 25, 2021. The transaction included participation from an accredited investor.お知らせ • Feb 06Bespoke Extracts Welcomes Trend Expert Carly Stojsic as New Director of MarketingBespoke Extracts, Inc. announced the appointment of industry trend expert Carly Stojsic as the company’s new Director of Marketing. Reporting directly to Bespoke CEO Danny Pollack, Stojsic will lead, guide and implement all aspects of the Company’s brand-building and product marketing strategies. For the past 15 years, Stojsic has applied her well-known and seasoned trend expertise to specialty and mass market brands operating within the lifestyle and retail industries. Her acumen in trend forecasting, presentation, unearthing innovative insights, achieving experiential customer engagement, and delivering impactful content marketing and market education, across all categories, has earned her distinction as a much sought after speaker and marketing advisor. For six years, Stojsic served as Market Editor and Senior Trend Specialist for WGSN, the global authority on consumer and design trends. In 2017, she was invited to present her macro consumer trend forecast, titled “The Builds and Collapses of Dimensions on the Trendscape” at MIT in Cambridge, Massachusetts. She has worked with brands that have included Gucci, Miu Miu (Prada Group), HBC, Joe Fresh, P&G, Starbucks and Walmart, among many others. Her consultative work in the cannabis space has included projects with 48North, Dosist, Calyx Wellness and various retailers, as well as brand management with Khalifa Kush Enterprises (Supreme Cannabis Company). Stojsic is perhaps best known in the industry for her ability to capture and captivate audiences with mind-blowing content.お知らせ • Jan 22Bespoke Extracts, Inc. announced that it has received $0.1 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced that it has entered into a securities purchase agreement for a private placement of 2,000,000 common shares at an issue price of $0.05 per share for gross proceeds of $100,000 on January 21, 2021. The transaction included participation from Chief Executive Officer of the company, Danil Pollack. The security issued is subject to hold period.お知らせ • Jan 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 01/14/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Jan 14Bespoke Extracts, Inc. Announces Its Plan to Reintroduce Umf® (Unique Manuka Factor) 15+ Rated Manuka Honey-Infused Cbd FormulationsBespoke Extracts, Inc. announced its plan to reintroduce UMF® (Unique Manuka Factor) 15+ rated Manuka Honey-infused CBD formulations to be available for purchase on www.bespokeextracts.com beginning in February 2021.お知らせ • Dec 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 11/30/2020, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Nov 25Bespoke Extracts, Inc. Introduces New Premium Product Line-Up of Seven Special CBD FormulationsBespoke Extracts, Inc. introduced a new line of specially-formulated, premium quality, hemp-derived CBD products now available for purchase in its ecommerce store. It introduced a new premium product line-up of seven special CBD formulations created specifically for “Women” and “Sport.” Bespoke’s products have been crafted so an individual can precisely tailor their use of its hemp-derived CBD tinctures and softgels to address their personal wellness objectives.お知らせ • Oct 20Bespoke Extracts, Inc. Appoints Yaniv Rozen as Chief Operating OfficerOn October 13, 2020, Yaniv Rozen was appointed chief operating officer of Bespoke Extracts, Inc. Mr. Rozen has been working as a consultant for start-up companies in the e-commerce industry for the last 5 years. On October 13, 2020, the company entered into a consulting agreement with Mr. Rozen pursuant to which the Company engaged Mr. Rozen to serve as the Company’s chief operating officer on a consultant/independent contractor basis. Mr. Rozen may engage in other business activities while serving as the Company’s chief operating officer.お知らせ • Sep 29Bespoke Extracts, Inc. announced that it has received $0.15 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced a private placement of a non-convertible promissory note in the principal amount of $150,000 on August 31, 2020. The transaction included participation from chief executive officer of the company, Danil Pollack. The note does not bear interest and matures on November 30, 2020. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Bespoke Extracts は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測OTCPK:BSPK - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数9/30/20251-100N/A6/30/20251-100N/A3/31/20251-100N/A12/31/20241-100N/A9/30/20241-100N/A6/30/20241-100N/A3/31/20241-100N/A12/31/20231-100N/A9/30/20231-2-1-1N/A6/30/20230-3-1-1N/A3/31/20230-4-1-1N/A12/31/20220-4-1-1N/A9/30/20220-300N/A6/30/20220-200N/A3/31/20220-100N/A12/31/20210000N/A11/30/20210-1-1-1N/A8/31/20210-1-1-1N/A5/31/20210-1-1-1N/A2/28/20210-4-1-1N/A12/31/20200-1-1-1N/A11/30/20200-4-1-1N/A8/31/20200-500N/A5/31/20200-5-1-1N/A2/29/20200-2-1-1N/A11/30/20190-2-1-1N/A8/31/201903N/A0N/A5/31/201901N/A-1N/A2/28/20190-1N/A-1N/A11/30/20180-3N/A-1N/A8/31/20180-8N/A-1N/A5/31/2018N/A-7N/A-1N/A2/28/2018N/A-9N/A-1N/A11/30/2017N/A-8N/A0N/A8/31/2017N/A-7N/A0N/A5/31/2017N/A-5N/A0N/A2/28/2017N/A0N/A0N/A11/30/2016N/A0N/A0N/A8/31/2016N/A0N/A0N/A5/31/2016N/A-1N/A0N/A2/29/2016N/A-1N/A0N/A11/30/2015N/A-1N/A0N/A8/31/2015N/A-1N/A0N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: BSPKの予測収益成長が 貯蓄率 ( 3.5% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: BSPKの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: BSPKの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: BSPKの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: BSPKの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: BSPKの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/18 10:42終値2026/05/06 00:00収益2025/09/30年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Bespoke Extracts, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Nov 13Bespoke Extracts, Inc. Provides Earnings Guidance for the Fourth Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the fourth quarter of 2025. For the period, the company expects Revenue: Projected between $425,000 and $500,000, up 41%–66% year-over-year, driven by continued demand for Fresh Joints and expansion of Doobskis and Dutch Blunts.
お知らせ • Aug 28Bespoke Extracts, Inc. Provides Earnings Guidance for the Third Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the third quarter of 2025. For the quarter, the company continue to experience sales growth in the new product lines compared the quarter ended September 30, 2024. The Company projects revenue between $425,000 and $450,000 for the quarter ending September 30, 2025, a 53% to 62% increase over $277,471 in the quarter ended September 30, 2024, driven by continued growth of FreshJoints, strong demand for Doobskis and Dutch Blunts, and expanded third-party processing services.
お知らせ • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2026, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Nov 13Bespoke Extracts, Inc. Provides Earnings Guidance for the Fourth Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the fourth quarter of 2025. For the period, the company expects Revenue: Projected between $425,000 and $500,000, up 41%–66% year-over-year, driven by continued demand for Fresh Joints and expansion of Doobskis and Dutch Blunts.
お知らせ • Aug 28Bespoke Extracts, Inc. Provides Earnings Guidance for the Third Quarter of 2025Bespoke Extracts, Inc. provided earnings guidance for the third quarter of 2025. For the quarter, the company continue to experience sales growth in the new product lines compared the quarter ended September 30, 2024. The Company projects revenue between $425,000 and $450,000 for the quarter ending September 30, 2025, a 53% to 62% increase over $277,471 in the quarter ended September 30, 2024, driven by continued growth of FreshJoints, strong demand for Doobskis and Dutch Blunts, and expanded third-party processing services.
お知らせ • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 03/31/2025, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Aug 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/14/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/14/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 02Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 04/01/2024, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Nov 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 11/14/2023, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • May 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 05/15/2023, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Nov 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 11/14/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 08/15/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 13Bespoke Extracts, Inc. (OTCPK:BSPK) entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million.Bespoke Extracts, Inc. (OTCPK:BSPK) entered into a definitive agreement to acquire the Assets of Osiris, LLC for $1.58 million on August 12, 2022. Upon closing, Bespoke will issue 125,000,000 shares of common stock in exchange for the assets of Osiris. 50 percent of these shares will be subject to a six-month lockup period and 50 percent will be subject to a twelve-month lockup period. Bespoke has also agreed to assume up to $125,000 of equipment-based financing following the transaction. Bespoke will also be entering into leases for the Aspen Dispensary, the Glenwood Cultivation Facility and the Glenwood Dispensary. The transaction has been approved by the boards of directors of Bespoke and the members of Osiris and is subject to customary closing conditions, including approvals from Colorado regulatory authorities. The transaction is expected to close in the fourth calendar quarter of 2022.
お知らせ • Jan 16Bespoke Extracts, Inc. announced delayed 10-Q filingOn 01/14/2022, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Dec 03Bespoke Extracts, Inc. (OTCPK:BSPK) agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million.Bespoke Extracts, Inc. (OTCPK:BSPK) agreed to acquire Assets of Wonderleaf, LLC from Wonderleaf, LLC for $0.23 million on December 2, 2021. Total consideration is to be paid 100% in Bespoke common shares. Bespoke will issue 2.5 million shares as a deposit, and an additional $0.15 of shares at closing according to the daily volume weighted average price of Bespoke common stock for the 30 consecutive trading days prior to closing. The proposed transaction has been unanimously approved by the Bespoke board of directors and is expected to close upon receipt of state and local regulatory approvals and satisfaction of other customary closing conditions.
お知らせ • Nov 30Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 11/29/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Apr 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 04/14/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Feb 26Bespoke Extracts, Inc. announced that it has received $0.5 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced a securities purchase agreement for a private placement of 10,000,000 shares at an issue price of $0.05 per share for gross proceeds $500,000 on February 25, 2021. The transaction included participation from an accredited investor.
お知らせ • Feb 06Bespoke Extracts Welcomes Trend Expert Carly Stojsic as New Director of MarketingBespoke Extracts, Inc. announced the appointment of industry trend expert Carly Stojsic as the company’s new Director of Marketing. Reporting directly to Bespoke CEO Danny Pollack, Stojsic will lead, guide and implement all aspects of the Company’s brand-building and product marketing strategies. For the past 15 years, Stojsic has applied her well-known and seasoned trend expertise to specialty and mass market brands operating within the lifestyle and retail industries. Her acumen in trend forecasting, presentation, unearthing innovative insights, achieving experiential customer engagement, and delivering impactful content marketing and market education, across all categories, has earned her distinction as a much sought after speaker and marketing advisor. For six years, Stojsic served as Market Editor and Senior Trend Specialist for WGSN, the global authority on consumer and design trends. In 2017, she was invited to present her macro consumer trend forecast, titled “The Builds and Collapses of Dimensions on the Trendscape” at MIT in Cambridge, Massachusetts. She has worked with brands that have included Gucci, Miu Miu (Prada Group), HBC, Joe Fresh, P&G, Starbucks and Walmart, among many others. Her consultative work in the cannabis space has included projects with 48North, Dosist, Calyx Wellness and various retailers, as well as brand management with Khalifa Kush Enterprises (Supreme Cannabis Company). Stojsic is perhaps best known in the industry for her ability to capture and captivate audiences with mind-blowing content.
お知らせ • Jan 22Bespoke Extracts, Inc. announced that it has received $0.1 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced that it has entered into a securities purchase agreement for a private placement of 2,000,000 common shares at an issue price of $0.05 per share for gross proceeds of $100,000 on January 21, 2021. The transaction included participation from Chief Executive Officer of the company, Danil Pollack. The security issued is subject to hold period.
お知らせ • Jan 15Bespoke Extracts, Inc. announced delayed 10-Q filingOn 01/14/2021, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Jan 14Bespoke Extracts, Inc. Announces Its Plan to Reintroduce Umf® (Unique Manuka Factor) 15+ Rated Manuka Honey-Infused Cbd FormulationsBespoke Extracts, Inc. announced its plan to reintroduce UMF® (Unique Manuka Factor) 15+ rated Manuka Honey-infused CBD formulations to be available for purchase on www.bespokeextracts.com beginning in February 2021.
お知らせ • Dec 01Bespoke Extracts, Inc. announced delayed annual 10-K filingOn 11/30/2020, Bespoke Extracts, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Nov 25Bespoke Extracts, Inc. Introduces New Premium Product Line-Up of Seven Special CBD FormulationsBespoke Extracts, Inc. introduced a new line of specially-formulated, premium quality, hemp-derived CBD products now available for purchase in its ecommerce store. It introduced a new premium product line-up of seven special CBD formulations created specifically for “Women” and “Sport.” Bespoke’s products have been crafted so an individual can precisely tailor their use of its hemp-derived CBD tinctures and softgels to address their personal wellness objectives.
お知らせ • Oct 20Bespoke Extracts, Inc. Appoints Yaniv Rozen as Chief Operating OfficerOn October 13, 2020, Yaniv Rozen was appointed chief operating officer of Bespoke Extracts, Inc. Mr. Rozen has been working as a consultant for start-up companies in the e-commerce industry for the last 5 years. On October 13, 2020, the company entered into a consulting agreement with Mr. Rozen pursuant to which the Company engaged Mr. Rozen to serve as the Company’s chief operating officer on a consultant/independent contractor basis. Mr. Rozen may engage in other business activities while serving as the Company’s chief operating officer.
お知らせ • Sep 29Bespoke Extracts, Inc. announced that it has received $0.15 million in fundingBespoke Extracts, Inc. (OTCPK:BSPK) announced a private placement of a non-convertible promissory note in the principal amount of $150,000 on August 31, 2020. The transaction included participation from chief executive officer of the company, Danil Pollack. The note does not bear interest and matures on November 30, 2020.